Genitourinary Cancer Learning Center CME/CE

• 10.50 90.50
  Treatment Approaches in Early-Stage Bladder Cancer
  Medscape Education Oncology November 08, 2022
  Did you know that bladder cancer is highly treatable in the localized stages? Learn more about the latest in treating early-stage bladder cancer.
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 20.50 30.50
  Antibody-Drug Conjugates 101: A Multidisciplinary Perspective of ADC Use in Solid Tumors
  Medscape Education Oncology October 31, 2022
  Thinking about using antibody-drug conjugates (ADCs) in patients with solid tumors? Join this discussion with our experts for strategies and perspectives.
  
  0.50 CEMIN 0.50 CEMIN

  
  Save
• 10.50 90.50
  Metastatic Castration-Resistant Prostate Cancer: Updates From the 2022 European Annual Meeting
  Medscape Education Oncology October 26, 2022
  Are you up-to-date on the latest data in metastatic castration-resistant prostate cancer (mCRPC) from the 2022 European Society of Medical Oncology Congress?
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 10.25 90.25
  Pathology State of Affairs: Underscoring the Value of Biomarker Testing for Solid Tumors 
  Medscape Education Pathology September 16, 2022
  Are you up to date with current best practices for biomarker testing in solid malignancies? Find out more here!
  
  0.25 CMEMIN 0.25 ABIM MOCMIN

  
  Save
• 10.50 90.50
  Treatment Intensification With Nonhormonal Strategies
  Medscape Education Oncology September 15, 2022
  Did you know that treatment intensification has been shown to improve outcomes for patients with hormone-sensitive prostate cancer (HSPC)?
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 10.50 90.50
  Treatment Intensification With Androgen Deprivation Therapy and Novel Hormonal Therapies
  Medscape Education Oncology August 30, 2022
  Are you up-to-date on all the treatment intensification options for your patients with metastatic hormone-sensitive prostate cancer (HSPC)?
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 10.50
  PARP Inhibitor Combination Regimens for Prostate Cancer Management
  Medscape Education Oncology August 26, 2022
  Do you know how PARP inhibitors exploit synthetic lethality to treat cancer?
  
  0.50 CMEMIN

  
  Save
• 10.50 90.50
  Conceptual Overview of Treatment Intensification in Hormone-Sensitive Prostate Cancer
  Medscape Education Oncology August 12, 2022
  What is treatment intensification for patients with hormone-sensitive prostate cancer (HSPC)?
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 10.50 90.50 20.50
  Optimizing Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer
  Medscape Education Oncology July 26, 2022
  Do you know the data on androgen deprivation therapy, chemotherapy, and second-generation antiandrogens for hormone-sensitive prostate cancer (mHSPC)?
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN

  
  Save
• 10.50 90.50
  The State of the Therapeutics in Genitourinary Cancers: Where Are We Moving the Needle?
  Medscape Education Oncology June 24, 2022
  Are you employing the latest therapies for your patients with genitourinary cancers?
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 20.50
  A Genitourinary Overview of Bladder and Prostate Cancers
  Medscape Education Nurses June 20, 2022
  Our nurse expert summarizes the latest in bladder and prostate cancer management.
  
  0.50 CEMIN

  
  Save
• 10.25 90.25
  Enhancing Equitable Cancer Care by Decreasing Disparities: Tools and Tips for Prostate Cancer
  Medscape Education Oncology June 20, 2022
  Do you know why Black men with prostate cancer are more likely to die from their disease than White men with prostate cancer (PC)?
  
  0.25 CMEMIN 0.25 ABIM MOCMIN

  
  Save
• Genomic Landscape of TCRαβ and TCRγδ T-Large Granular Lymphocyte Leukemia
  Blood May 19, 2022
  In LGL leukemia, STAT3 mutations are linked to mutational burden and neutropenia; select STAT3-activating mutations are linked to anemia.
  
  
  Save
• 11.50
  Data-driven Debates on the Evolving Bladder Cancer Landscape: Harnessing Novelty to Improve Outcomes
  Medscape Education Oncology May 02, 2022
  Are you up to date with the clinical trial data for neoadjuvant and adjuvant therapeutic options in bladder cancer?
  
  1.50 CMEMIN

  
  Save
• 10.50 90.50 20.50 30.50
  Interprofessional Clinic: A Team-Based Approach to Oral Therapies in Prostate Cancer
  Medscape Education Oncology April 01, 2022
  Did you know that patient outcomes and clinical management may be improved by implementing a multidisciplinary approach to prostate cancer care?
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN 0.50 CEMIN

  
  Save
• 11.00 91.00
  Patient Simulations in Personalized Planning for Prostate Cancer
  Medscape Education Oncology March 22, 2022
  Explore nuances in the individualized treatment of prostate cancer
  
  1.00 CMEMIN 1.00 ABIM MOCMIN

  
  Save
• 10.50 90.50 20.50 30.50
  Exploring the Role of Immunotherapy in Advanced Non-Small Cell Lung Cancer Without Targetable Mutations
  Medscape Education Oncology March 11, 2022
  Experts discuss the role of immunotherapy in advanced non-small cell lung cancer without targetable mutations.
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN 0.50 CEMIN

  
  Save
• 11.00 91.00
  How Will You Manage These Patients With Prostate Cancer? Practice Your Skills in This Virtual Patient Simulation
  Medscape Education Oncology February 04, 2022
  Review updated guidelines for the diagnosis and treatment of prostate cancer
  
  1.00 CMEMIN 1.00 ABIM MOCMIN

  
  Save
• 10.50
  Refocusing the Image: Diagnostic Imaging Within Prostate Cancer
  Medscape Education Radiology February 03, 2022
  Learn how to integrate modern methods of prostate cancer imaging into your practice and how it can lead to better outcomes.
  
  0.50 CMEMIN

  
  Save
• 10.50 90.50 20.50
  Personalizing Cancer Care in Nonmetastatic Castration-Resistant Prostate Cancer
  Medscape Education Oncology January 25, 2022
  Learn how an interprofessional team collaborates to manage the treatment of patients with nmCRPC.
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN

  
  Save